首页    期刊浏览 2025年02月20日 星期四
登录注册

文章基本信息

  • 标题:LPA receptor signaling: pharmacology, physiology, and pathophysiology
  • 本地全文:下载
  • 作者:Yun C. Yung ; Nicole C. Stoddard ; Jerold Chun
  • 期刊名称:JLR Papers In Press
  • 印刷版ISSN:0022-2275
  • 电子版ISSN:1539-7262
  • 出版年度:2014
  • 卷号:55
  • 期号:7
  • 页码:1192-1214
  • DOI:10.1194/jlr.R046458
  • 语种:English
  • 出版社:American Society for Biochemistry and Molecular Biology
  • 摘要:Lysophosphatidic acid (LPA) is a small ubiquitous lipid found in vertebrate and nonvertebrate organisms that mediates diverse biological actions and demonstrates medicinal relevance. LPA’s functional roles are driven by extracellular signaling through at least six 7-transmembrane G protein-coupled receptors. These receptors are named LPA1–6 and signal through numerous effector pathways activated by heterotrimeric G proteins, including Gi/o, G12/13, Gq, and Gs. LPA receptor-mediated effects have been described in numerous cell types and model systems, both in vitro and in vivo, through gain- and loss-of-function studies. These studies have revealed physiological and pathophysiological influences on virtually every organ system and developmental stage of an organism. These include the nervous, cardiovascular, reproductive, and pulmonary systems. Disturbances in normal LPA signaling may contribute to a range of diseases, including neurodevelopmental and neuropsychiatric disorders, pain, cardiovascular disease, bone disorders, fibrosis, cancer, infertility, and obesity. These studies underscore the potential of LPA receptor subtypes and related signaling mechanisms to provide novel therapeutic targets.
  • 关键词:lysophosphatidic acid ; lysophospholipid ; autotaxin ; brain lipids ; cancer ; fibrosis ; reproduction ; obesity ; pain ; atherosclerosis
国家哲学社会科学文献中心版权所有